Frequency of mutations in PRKN, PINK1, and DJ1 in Patients With Early-Onset Parkinson Disease from neighboring countries in Central Europe.
暂无分享,去创建一个
M. Barcikowska | J. Siuda | G. Opala | Z. Wszolek | I. Rektorová | P. Janik | O. Ross | D. Hoffman-Zacharska | J. Sławek | R. Walton | D. Koziorowski | A. Friedman | A. Krygowska-Wajs | K. Śmiłowska | L. Szczechowski | M. Boczarska-Jedynak | M. Rudzińska-Bar | Y. Sanotsky | A. Potulska‐Chromik | Z. Jamrozik | Łukasz M Milanowski | B. Jasińska-Myga | A. Deutschlander | Alexandra I. Soto-Beasley | J. Dulski | Lyuda Fedoryshyn | Aleksander Pulyk | Jennifer A. Lindemann | Gabriela Kłodowska | Katherine Karpinsky
[1] J. Elder,et al. Advancing gene therapies, methods, and technologies for Parkinson's Disease and other neurological disorders. , 2020, Neurologia i neurochirurgia polska.
[2] M. Nalls,et al. Comprehensive assessment of PINK1 variants in Parkinson's disease , 2020, Neurobiology of Aging.
[3] J. Jankovic,et al. Juvenile parkinsonism: Differential diagnosis, genetics, and treatment. , 2019, Parkinsonism & related disorders.
[4] L. Pihlstrøm,et al. Deep brain stimulation and genetic variability in Parkinson’s disease: a review of the literature , 2019, npj Parkinson's Disease.
[5] L. Menalled,et al. The Michael J. Fox Foundation for Parkinson’s Research Strategy to Advance Therapeutic Development of PINK1 and Parkin , 2019, Biomolecules.
[6] E. Broussolle,et al. What a neurologist should know about PET and SPECT functional imaging for parkinsonism: A practical perspective. , 2019, Parkinsonism & related disorders.
[7] I. König,et al. Genotype‐Phenotype Relations for the Parkinson's Disease Genes Parkin, PINK1, DJ1: MDSGene Systematic Review , 2018, Movement disorders : official journal of the Movement Disorder Society.
[8] Andrew B Singleton,et al. Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance , 2016, Journal of neurochemistry.
[9] C Büchel,et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia , 2007, Neurology.
[10] G. Schellenberg,et al. Heterozygous parkin point mutations are as common in control subjects as in Parkinson's patients , 2007, Annals of neurology.
[11] A. Lieberman,et al. Parkinson's disease: a clinical review. , 1974, The American journal of the medical sciences.